Not Yet Recruiting
Testing the Efficacy, Safety, and PK of 20E in Patients With Obesity Who Are Starting Treatment With the GLP-1 Agonist Semaglutide for Weight Loss.
NCT07411378
- Conditions
- Atrophy, Body Weight, Muscle Wasting, +13 more
- Locations
-
Not specified